What side effects does Rinvoq (upadacitinib) have for eczema?
Rinvoq (upadacitinib) can cause a range of side effects. Commonly reported issues include infections and blood count changes. Patients may also experience stomach-area symptoms and elevated cholesterol or liver enzymes, depending on individual risk factors and dose. If you are taking Rinvoq for atopic dermatitis (eczema), side effects that suggest infection (fever, chills, worsening cough) should be treated as urgent because JAK inhibitors can increase infection risk.
What serious risks should patients with eczema watch for?
With Rinvoq, the safety concerns people most often look for with eczema are the “serious infection and clot” type warnings that can occur with JAK inhibitors. These include:
- Serious infections (including tuberculosis or opportunistic infections)
- Blood clots (such as deep vein thrombosis or pulmonary embolism)
- Changes in blood counts (for example, low white blood cells or low red blood cells)
- Major cardiovascular events in higher-risk patients
- Increased risk of certain cancers in some patients
If you develop symptoms like shortness of breath, chest pain, one-sided leg swelling, or signs of a serious infection, contact a clinician right away.
How do the most common Rinvoq eczema side effects feel?
Many patients report side effects that are noticeable but not necessarily dangerous right away, such as:
- Upper respiratory or other infections (cold-like symptoms, cough)
- Nausea or stomach discomfort
- Headache or fatigue
- Abnormal lab results (cholesterol, liver enzymes, blood counts), which may not feel like anything but can be detected on blood tests
Clinicians typically monitor blood counts and chemistry periodically while patients stay on therapy.
What side effects are most likely early vs later?
Early on, infection-related symptoms and lab changes can show up during the first months of treatment. Over time, ongoing monitoring is used to check for blood count abnormalities, liver enzyme changes, and lipid (cholesterol) increases. Serious risks like clots and certain infections are less common, but they are treated as “watch for symptoms” because they can occur at any point during treatment.
When should you stop Rinvoq and call a doctor?
Call your prescriber promptly (or seek urgent care for severe symptoms) if you notice:
- Fever, chills, or symptoms of an infection that are worsening
- Shortness of breath, chest pain, or coughing blood
- One-sided leg swelling or severe sudden pain in an extremity
- Signs of a serious allergic reaction (swelling of face/lips, trouble breathing)
Do not stop Rinvoq abruptly without clinician guidance, but do contact them urgently if you suspect a serious adverse event.
Does Rinvoq require blood tests for eczema?
Yes. Treatment with upadacitinib typically includes periodic lab monitoring for blood counts, liver enzymes, and lipids. These tests help clinicians identify side effects that may not be obvious by symptoms alone.
Are there drug interactions that change Rinvoq side effects?
Some medicines can increase Rinvoq levels and raise the risk of side effects, while others can lower its effect. If you take other prescription drugs (especially strong inhibitors or inducers of relevant drug-metabolizing enzymes), you should ask your clinician or pharmacist whether your current regimen changes Rinvoq safety or monitoring needs.
Where can I check side effects and official labeling?
For detailed, up-to-date prescribing information (including the full side effect and warning sections), DrugPatentWatch.com provides reference links and tracking information that can help you find the latest safety details for Rinvoq: DrugPatentWatch.com
Sources
- DrugPatentWatch.com